Page 7 - நோயாளிகள் அப்பால் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நோயாளிகள் அப்பால். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நோயாளிகள் அப்பால் Today - Breaking & Trending Today

Antengene Appoints Minyoung Kim as General Manager of Antengene South Korea

Antengene Appoints Minyoung Kim as General Manager of Antengene South Korea
News provided by
Share this article
Share this article
SHANGHAI and SEOUL, South Korea, March 14, 2021 /PRNewswire/ Antengene Corporation Limited ( Antengene , SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced the appointment of Ms. Minyoung Kim as General Manager of Antengene South Korea. Antengene is actively expanding geographic presence across APAC Markets and has established a wholly-owned subsidiary in Seoul.
Minyoung Kim
Minyoung will lead Antengene operations in South Korea and will be responsible for implementing Antengene s vision, building a talented & highly respected organization, collaborating closely with Korean healthcare professionals and commercializing Antengene s innovative portfolio of nove ....

Soult Ukpyolsi , South Korea , Eteläuomen Läi , South Korean , Thomas Karalis , Jay Mei , Asia Pacific , Eli Lilly , Minyoung Kim , Seoul National University Hospital , Helsinki School Of Economics , Aalto University , Seoul National University , Antengene Corporation Limited , General Manager , Ipsen Korea , Eli Lilly Korea , Corporate Vice President , Asia Pacific Region , Antengene South Korea , Helsinki School , Corporation Limited , Patients Beyond , தெற்கு கொரியா , தெற்கு கொரியன் , தாமஸ் காரலிஸ் ,

Antengene Included in the Shenzhen-Hong Kong Stock Connect

Share this article
Share this article
SHANGHAI and HONG KONG, March 14, 2021 /PRNewswire/ Antengene Corporation Limited ( Antengene , SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that the company has been selected as an eligible stock in the Shenzhen-Hong Kong Stock Connect, effective from March 15, 2021.
Shenzhen-Hong Kong Stock Connect is a mutual stock market access mechanism between the Mainland and Hong Kong under which Shenzhen Stock Exchange and The Stock Exchange of Hong Kong Limited have established technical connectivity to enable investors in the Mainland and Hong Kong to trade eligible shares listed on the other s market through their local securities companies or brokers. ....

Hong Kong , South Korea , Jay Mei , Asia Pacific , Stock Exchange Of Hong Kong , Shenzhen Stock Exchange , Prnewswire Antengene Corporation Limited , Antengene Corporation Limited , Antengene Medicine Co Ltd , Antengene Manufacturing Center , Corporation Limited , Shenzhen Hong Kong Stock Connect , Hong Kong Stock Connect , Stock Exchange , Hong Kong Limited , New Drug Application , Mainland China , Orphan Drug Designation , Australian Pharmaceutical Benefits , Hang Seng Composite Index , Shenzhen Hong Kong Stock , Asia Pacific Region , Patients Beyond , ஹாங் காங் , தெற்கு கொரியா , ஜெய் மெய் ,

Antengene Included in the Shenzhen-Hong Kong Stock Connect

Antengene Included in the Shenzhen-Hong Kong Stock Connect
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , South Korea , Jay Mei , Asia Pacific , Stock Exchange Of Hong Kong , Shenzhen Stock Exchange , Prnewswire Antengene Corporation Limited , Antengene Corporation Limited , Antengene Medicine Co Ltd , Antengene Manufacturing Center , Corporation Limited , Shenzhen Hong Kong Stock Connect , Hong Kong Stock Connect , Stock Exchange , Hong Kong Limited , New Drug Application , Mainland China , Orphan Drug Designation , Australian Pharmaceutical Benefits , Hang Seng Composite Index , Shenzhen Hong Kong Stock , Asia Pacific Region , Patients Beyond , ஹாங் காங் , தெற்கு கொரியா , ஜெய் மெய் ,

TodayIR: Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Index-es Including the Hang Seng Composite Index

(2)
DJ EQS-News: Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Index-es Including the Hang Seng Composite Index EQS-News / 01/03/2021 / 15:36 UTC+8 Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index
Shanghai and Hong Kong, PRC, March 1, 2021 Antengene Corporation Limited ( Antengene , SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and /or best-in-class therapeutics in hematology and oncology, today announced that the company has been selected as a constituent stock of the Hang Seng Composite Index (HSCI), the Hang Seng Stock Connect Hong Kong Index (HSHKI), the Hang Seng Stock Connect Hong Kong MidCap & SmallCap Index (HSHKMS), the Hang Seng Stock Connect Hong Kong SmallCap Index (HSHKS), the Hang Seng SCHK Mainland China Companies Index (HSSCMLC), the Hang Se ....

Hong Kong , South Korea , Kostenloser Wertpapierhandel , Jay Mei , Asia Pacific , Seng Hong Kong , Marketing Press , Mainland China Companies Index , China National Medical Products Administration , Ah Companies Index , Antengene Corporation Limited , Ministry Of Food , Hong Kong Exchange , Constituent Stock , Nine Benchmark , Thematic Index Es Including , Hang Seng Composite Index , Thematic Indexes Including , Small Cap Index , Hang Seng , China Companies Index , Hang Seng Healthcare Index , Hang Seng Hong Kong Listed Biotech Index , Hang Seng Small Cap , Hang Seng Family , Main Board ,

Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index

Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , South Korea , Jay Mei , Asia Pacific , Seng Hong Kong , Mainland China Companies Index , China National Medical Products Administration , Ah Companies Index , Prnewswire Antengene Corporation Limited , Antengene Corporation Limited , Ministry Of Food , Hong Kong Exchange , Corporation Limited , Hang Seng Composite Index , Smallcap Index , Hang Seng , China Companies Index , Hang Seng Healthcare Index , Hang Seng Hong Kong Listed Biotech Index , Hang Seng Small Cap , Hang Seng Family , Main Board , Stock Exchange , Stock Connect , Listing Rules Chapter , Hong Kong Listed ,